Filing Details
Pyxis Oncology, Inc. (NASDAQ:PYXS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PYXS
Pyxis Oncology, Inc. (PYXS) Files Quarterly Report for Q0
Pyxis Oncology, Inc. (NASDAQ:PYXS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Pyxis Oncology, Inc. (NASDAQ:PYXS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Pyxis Oncology, Inc. filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $3.01 with a market capitalization of $274.2 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Pyxis Oncology, Inc.'s stock currently trades at $3.01 with a market capitalization of $274.2M.
The 10-Q provides Pyxis Oncology, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Pyxis Oncology, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PYXS Stock Page
Frequently Asked Questions
Where can I read PYXS's SEC filings?
Browse all filings on our PYXS SEC filings page.
What types of SEC filings does Pyxis Oncology, Inc. file?
Public companies like Pyxis Oncology, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.